Biophan develops and markets cutting-edge technologies for the medical device industry. The Company's goals are to develop biomedical devices capable of safely working with magnetic resonance imaging (MRI) systems and to provide other technologies that improve the delivery of healthcare. These technologies enable implants such as pacemakers and stents, and interventional surgical devices including guidewires and catheters, to be safely and effectively imaged under MRI.
Biophan also has a minority interest in MYOTECH, LLC, with an option to take a majority position, to help develop and commercialize the MYO-VAD™, a novel, MRI-compatible cardiac support system that has significant potential for improving the treatment of many forms of heart disease.
Committed to growth through innovation and developmental leadership, Biophan and its licensors now hold a total of 56 issued U.S. patents and over 100 pending applications at various stages of examination at the U.S. Patent and Trademark Office.
Biophan has joint development and licensing agreements with Boston Scientific Corporation and NASA Ames Center for Nanotechnology.